| |
|
|
|
Aptevo Therapeutics Inc  
|
|
33.55 0.43 (0.01%) |
01-22 16:00 |
|
Open: |
32.79 |
Pre close: |
33.12 |
Target:
|
43.83 
|
|
High: |
33.55 |
Low: |
31.12 |
Resistance:
|
37.53
41.79
|
|
Volume: |
137,876 |
Market Cap: |
147M |
Support:
|
30.63
25.48
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
32.45
|
MACD |
MACD(12,26):
|
-1.36  |
|
MA(20): |
35.07 |
Signal(12,26,9): |
-1.00 |
|
MA(100): |
24.28 |
Stochastic Oscillator |
%K(14,3):
|
27.09 |
|
MA(250): |
13.51 |
%D(3): |
17.24 |
|
Average Volume(K) |
3-Month: |
188345
|
52-Week |
High:
|
60.00 |
|
10-Days: |
9710 |
Low: |
2.94 |
|
RSI |
RSI(14):
|
43.02 |
Change(%): |
281.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.840 |
Return on Equity (ttm) |
-317.0 |
Shares Out. (M) |
4.38 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-38.6 |
Shares Float (M) |
1.35 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.93 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
75.18 |
|
Forward EPS |
-0.990 |
Gross Profit (p.s.) |
-3.941 |
Shares Short (K) |
166 |
|
Book Value (p.s.) |
0.680 |
EBITDA (p.s.) |
-6.541 |
P/E |
-5.74 |
|
Sales Per Share |
7.845 |
Qtrly Earnings Growth |
0.00 |
P/BV |
49.34 |
|
Profit Margin |
-54.92 |
Operating Cash Flow
(M) |
-28.30 |
P/S |
4.28 |
|
Operating Margin |
-88.02 |
Levered Free Cash Flow
(M) |
-12.28 |
P/CF |
-5.19 |
|
|
|
|
|
|
